About the Company
We do not have any company description for Allovir, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ALVR News
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
THE LAWSUIT: A class action securities lawsuit was filed against AlloVir, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 22, ...
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
THE LAWSUIT: A class action securities lawsuit was filed against AlloVir, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 22 ...
ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the ...
AlloVir Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
AlloVir Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
AlloVir, Inc. (ALVR) Stock Historical Prices & Data - Yahoo Finance
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Who Got The Work
Caroline H. Bullerjahn, Justin D. Ward and Brendan Blake from Goodwin Procter have entered appearances for drug developer AlloVir and its top corporate officers in a pending securities class action.
AlloVir, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws ...
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws ...
Loading the latest forecasts...